Clinically useful antituberculosis agent that is active (MIC’s 0.030 to 0.120 µg/mL) against multi-drug resistant strains. It interferes with mycobacterial energy metabolism via binding to the oligomeric subunit c (AtpE) and subunit ε of ATP synthase inhibiting ATP production. Bedaquiline has...
Know who made it. See the evidence. Buy through one marketplace.
Clinically useful antituberculosis agent that is active (MIC’s 0.030 to 0.120 µg/mL) against multi-drug resistant strains. It interferes with mycobacterial energy metabolism via binding to the oligomeric subunit c (AtpE) and subunit ε of ATP synthase inhibiting ATP production. Bedaquiline has recently been found to be an inhibitor (IC50 = 18.7 µM) of the SARS-CoV-2 main protease, 3CLpro
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
